Your browser doesn't support javascript.
loading
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.
Mazzoni, Alessio; Maggi, Laura; Capone, Manuela; Spinicci, Michele; Salvati, Lorenzo; Colao, Maria Grazia; Vanni, Anna; Kiros, Seble Tekle; Mencarini, Jessica; Zammarchi, Lorenzo; Mantengoli, Elisabetta; Menicacci, Lorenzo; Caldini, Eleonora; Romagnani, Sergio; Liotta, Francesco; Morettini, Alessandro; Rossolini, Gian Maria; Bartoloni, Alessandro; Cosmi, Lorenzo; Annunziato, Francesco.
Afiliação
  • Mazzoni A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Maggi L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Capone M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Spinicci M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Salvati L; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
  • Colao MG; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Vanni A; Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.
  • Kiros ST; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Mencarini J; Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.
  • Zammarchi L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Mantengoli E; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
  • Menicacci L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Caldini E; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
  • Romagnani S; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
  • Liotta F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Morettini A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Rossolini GM; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Bartoloni A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Cosmi L; Immunology and Cell Therapy Unit, Careggi University Hospital, Florence, Italy.
  • Annunziato F; Internal Medicine 2 Unit, Careggi University Hospital, Florence, Italy.
Eur J Immunol ; 50(12): 2013-2024, 2020 Dec.
Article em En | MEDLINE | ID: mdl-33080068
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Portador Sadio / Imunidade Humoral / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies Limite: Adult / Female / Humans Idioma: En Revista: Eur J Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Portador Sadio / Imunidade Humoral / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies Limite: Adult / Female / Humans Idioma: En Revista: Eur J Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália